Sishengtang decoction in alleviation of toxic and side effects of transarterial embolization

Table 1 Effects of Sishengtang decoction and RCAS on clinical symptoms of TAE patients (x^-± s)

Groups	n	Significant improvement	Improvement	No improvement	Improvement rate (%)
Sishengtang decoction (34)
Lassitue	28	14	12	2	93.9
Poor appetite	23	12	9	2	91.3
Nausea	23	11	9	3	86.9
Control (20)
Lassitue	17	6	6	5	70.1a
Poor appetite	12	5	3	4	66.7a
Nausea	14	4	7	3	78.9a

^aP < 0.05 vs Sishengtang decoction

Table 2 Laboratory indexes of TAE patients in Sishengtang decoction group and control group (x^-± s)

Groups	n	WBC (× 109/L)	PLT (× 109/L)	NK activities (%)	LAK activities (%)
Sishengtang decoction	34
Before treatment		4.62 ± 0.62	123.00 ± 37.45	32.03 ± 7.25	34.07 ± 6.69
After treatment		4.44 ± 0.63	116.23 ± 29.42	31.04 ± 6.92	32.03 ± 6.76
Control	20
Before treatment		5.31 ± 0.82	31.92 ± 47.93	141.20 ± 5.22	32.87 ± 4.85
After treatment		3.87 ± 0.38	126.80 ± 37.58	26.16 ± 7.77a	27.16 ± 5.74a

^aP < 0.05 vs before treatment in control